Webinar | Generic Drug Labeling, Product Liability, and the Changing FDA Regulatory Landscape
The webinar will take place Tuesday, March 11, 2014 at 2:00 p.m. ET.
Pending CLE certification:
This program is pending approval for CLE credit in New York and California. For all other jurisdictions, attendees will receive a Uniform Certificate of Attendance.
Note to NY Lawyers:
This program is appropriate for non-transitional lawyers, but not acceptable for newly admitted lawyers.
For any questions regarding this event, please contact Kristen Walker.
For the latest government regulatory developments please visit us at Focus on Regulation at www.hlregulation.com
On 26 September 2016, a new EU-US collaboration between the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) was announced. This new collaboration is ...06 October 2016
On 1 September 2016, the European Medicines Agency ("EMA") opened for public consultation a Draft revision to its Guideline on the assessment of clinical safety and efficacy in the...08 September 2016